U.S. Construction Stock News

NasdaqGS:MYRG
NasdaqGS:MYRGConstruction

Assessing MYR Group (MYRG) Valuation After A Sharp Multi Month Share Price Surge

Event context and recent stock move MYR Group (MYRG) has drawn investor attention after a sharp recent share price move, with the stock up about 48% over the past month and about 59% in the past 3 months. See our latest analysis for MYR Group. While the share price has pulled back 6.0% in the last day to US$427.38, momentum over longer periods remains strong. The 30 day share price return is about 48%, and the 1 year total shareholder return is about 176%, hinting at a sharp reassessment of...
NasdaqGS:FROG
NasdaqGS:FROGSoftware

JFrog’s Q1 Beat Puts AI Growth And Buybacks In Focus

JFrog (NasdaqGS:FROG) reported a strong Q1 2026, with robust revenue growth and faster cloud adoption. The company highlighted new AI driven capabilities across its platform, focused on software supply chain security. Management raised full year guidance and the board authorized a major share repurchase program. JFrog operates at the intersection of software delivery, DevOps, and security, areas that sit at the core of how modern applications are built and maintained. The fresh focus on AI...
NYSE:DVN
NYSE:DVNOil and Gas

Assessing Devon Energy (DVN) Valuation After Recent Pullback And Narrative Of Undervaluation

What Recent Performance Says About Devon Energy (DVN) Devon Energy (DVN) has drawn attention after a recent pullback, with the stock showing a 2.8% decline in the latest session and an 11.8% decline over the past week. Over the past month the stock shows a 9.3% decline, while the past 3 months are in positive territory, supported by a 19.6% year to date return and a 45.6% total return over the past year. See our latest analysis for Devon Energy. The recent 1 day share price return of negative...
NYSE:ALL
NYSE:ALLInsurance

Assessing Allstate (ALL) Valuation After Recent Mixed Share Price Performance

Why Allstate Stock Is On Investors’ Radar Today Allstate (ALL) is drawing attention after recent share moves, with the stock showing mixed returns over the past week and month, while longer term performance and current valuation metrics give investors more to think about. See our latest analysis for Allstate. Allstate’s recent 1 day share price decline of 1.95% and softer 7 day share price return of 1.65% sit alongside a positive year to date share price return of 4.83% and a 1 year total...
NasdaqGS:MDLZ
NasdaqGS:MDLZFood

Is Mondelez International (MDLZ) Priced Attractive After Recent Share Price Rebound?

Wondering if Mondelez International at around US$61.31 is offering good value right now, or if you would be overpaying for its future cash flows? The stock has returned 6.6% over the last 30 days and 14.3% year to date, but the 1-year return of a 5.8% decline and the 3-year return of a 14.9% decline show that recent strength follows a weaker period. Recent coverage of Mondelez International has focused on how investors are reassessing large branded food stocks in light of changing consumer...
NYSE:DOC
NYSE:DOCHealth Care REITs

Healthpeak Properties (DOC) Is Up 21.6% After Raising 2026 EPS Outlook on Janus Living IPO

In early May 2026, Healthpeak Properties, Inc. reported first-quarter 2026 results showing higher revenue of US$752.95 million and net income of US$193.63 million, and raised its full-year 2026 diluted EPS guidance to US$0.46–US$0.50. The stronger outlook was underpinned by the Janus Living IPO, which generated about US$880 million while leaving Healthpeak with an 81.6% stake, alongside senior housing acquisitions, a Blackstone joint venture, and share repurchases. Next, we’ll examine how...
NasdaqGS:FSLR
NasdaqGS:FSLRSemiconductor

Is It Too Late To Consider First Solar (FSLR) After Its Strong Multi Year Run

If you are wondering whether First Solar at around US$214.57 is still good value after its strong run, this article walks through what the current price actually reflects. The stock has moved 6.3% over the last 7 days, 11.6% over 30 days, 60.4% over 1 year and 208.4% over 5 years. Year to date, the return stands at a 21.8% decline, which can change how you think about both upside and risk. Recent coverage has focused on First Solar as part of ongoing interest in US-listed solar and...
NYSE:AXTA
NYSE:AXTAChemicals

Assessing Axalta Coating Systems (AXTA) Valuation After Softer Earnings And Flat Near‑Term Growth Outlook

Axalta Coating Systems (AXTA) shares have been reacting to fresh first quarter results, with sales of US$1,254 million and net income of US$90 million, along with guidance calling for flat second quarter net sales growth. See our latest analysis for Axalta Coating Systems. The first quarter update and cautious outlook appear to be weighing on sentiment, with Axalta Coating Systems’ recent 9.34% 1 month share price return still sitting against a weaker 1 year total shareholder return of...
NYSE:DRD
NYSE:DRDMetals and Mining

DRDGOLD (DRD) Is Up 5.2% After Debt-Free Growth And Lower Costs Is The Bull Case Changing?

DRDGOLD recently reported a stronger quarter to 31 March 2026, with higher revenue, increased gold production, improved yields and lower cash operating costs per kilogram. An interesting aspect of the update is that DRDGOLD continues to fund its growth projects without taking on debt, underscoring a disciplined capital approach. Next, we’ll examine how DRDGOLD’s combination of higher production and reduced cash operating costs could influence the company’s broader investment narrative. Find...
NYSE:MRP
NYSE:MRPSpecialized REITs

Millrose Properties (MRP) Is Down 12.3% After Surging Q1 Revenue And Net Income Report

Millrose Properties, Inc. has reported past first-quarter 2026 results, with revenue rising to US$194.93 million and net income to US$122.88 million, both significantly higher than the same period a year earlier. The sharp increase in revenue relative to the prior year's US$82.70 million highlights how much more transaction activity Millrose is now channeling through its land banking model. We will now examine how this sharp jump in quarterly revenue and net income affects Millrose...
NasdaqGS:EXC
NasdaqGS:EXCElectric Utilities

Is It Time To Reassess Exelon (EXC) After Recent Share Price Weakness?

Investors may be assessing whether Exelon at around US$44.41 is offering fair value today, or if the current price is mispricing the long term story. The stock has slipped 3.4% over the last 7 days and 9.5% over the last 30 days, while the 1 year return sits at 2.0% and the 5 year return at 65.7%. Recent attention on Exelon has centered on its role as a large regulated utility. Investors are watching how its business mix and capital plans fit into long term energy and grid needs. This...
NasdaqGS:LFUS
NasdaqGS:LFUSElectronic

Littelfuse (LFUS) Is Up 9.3% After Q1 Beat And Basler Outperformance Has The Bull Case Changed?

In early May 2026, Littelfuse reported first-quarter 2026 results showing sales rising to US$656.97 million and net income to US$75.15 million, with earnings per share roughly doubling from a year earlier. Management highlighted that the Basler acquisition outperformed initial expectations and, alongside broad-based demand across electronics, transportation, and industrial markets, is supporting margin expansion and a confident outlook for further acquisitions. With Q1 results beating...
NasdaqGS:CAI
NasdaqGS:CAIBiotechs

Is It Time To Reconsider Caris Life Sciences (CAI) After 26.5% Year To Date Decline?

If you are trying to work out whether Caris Life Sciences at around US$19.84 is attractively priced or not, you will want a clear view of what that tag really reflects. The stock has recently shown mixed momentum, with a 4.4% return over the last 7 days and 5.8% over the last month, while the year to date return stands at a 26.5% decline. Recent headlines around Caris Life Sciences have focused on its role in precision medicine and diagnostics, alongside ongoing attention to how it funds and...
NasdaqGS:INTC
NasdaqGS:INTCSemiconductor

Intel Gains U.S. Approval To Deepen SambaNova AI Collaboration

U.S. regulators have cleared Intel to increase its investment in AI chip developer SambaNova. The approval allows Intel to deepen its collaboration with SambaNova across generative AI chip and systems development. This clearance marks a new step in Intel's effort to build a broader position in advanced AI workloads beyond traditional CPUs. Intel, NasdaqGS:INTC, is drawing attention as it leans further into AI alongside its established CPU and foundry activities. The stock last closed at...
NYSE:BSX
NYSE:BSXMedical Equipment

Boston Scientific Governance Shift Raises Questions On Investor Influence

Boston Scientific (NYSE:BSX) stockholders approved the removal of supermajority voting requirements at a recent shareholder meeting. Shareholders also adopted officer exculpation protections and approved new shares for the Employee Stock Purchase Plan. Proposals to allow shareholders to call special meetings and other changes to shareholder rights were put forward but did not pass. Boston Scientific enters these governance changes with its stock at $56.57 and a mixed return profile. The...